DUBLIN--(BUSINESS WIRE)--Aug 20, 2018--The "Protein Binding Assays Market by Technology (Equilibrium Dialysis, Ultrafiltration, Ultracentrifugation, Gel Filtration Chromatography), End User (Pharmaceutical & Biotechnology Companies, Contract Research Organization) - Global Forecast to 2023" report has been added to ResearchAndMarkets.com's offering.

The protein binding assay market is projected to reach USD 425.7 million in 2023 from USD 256.1 million in 2018, at CAGR of 10.7% during the forecast period.

Factors such as the growing number of drug discovery activities, increasing pressure to reduce drug discovery and development costs, and the increase in pharmaceutical R&D expenditure are driving market growth. Issues concerning existing technologies and the development of in silico-based prediction models are expected to challenge market growth to a certain extent.

By end user, the protein binding assay market is divided into pharmaceutical & biotechnology companies, CROs, and other end users. In 2018, the pharmaceutical & biotechnology companies segment is expected to account for the largest share of the protein binding assay market. Protein binding assays play a pivotal role in ADME procedures, owing to which they are widely used by pharmaceutical & biotechnology companies to evaluate drug candidates based on their binding capacity with proteins.

On the basis of technology, the protein binding assay market is segmented into equilibrium dialysis, ultrafiltration, ultracentrifugation, and other technologies. The equilibrium dialysis segment is expected to account for the largest share of the protein binding assay market. The large share and high growth rate of this segment can be attributed to the advantages associated with the use of equilibrium dialysis, which include physical simplicity, low costs, and high accuracy. The simpler workflow equilibrium dialysis also makes it the preferred choice for protein binding studies.

Key Topics Covered

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Protein Binding Assay Market, By Technology

7 Protein Binding Assay Market, By End-User

8 Protein Binding Assay Market, By Region

9 Competitive Landscape

10 Company Profiles

3B Pharmaceuticals Absorption Systems ADMEcell Biotium Danaher Corporation Eurofins Scientific GE Healthcare HTDialysis Merck Sovicell GmbH Thermo Fisher Scientific

For more information about this report visit https://www.researchandmarkets.com/research/8f7597/the_global_market?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180820005473/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: RESEARCH SCIENCE

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 08/20/2018 12:22 PM/DISC: 08/20/2018 12:22 PM

http://www.businesswire.com/news/home/20180820005473/en